Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
826.00    0.00 (0.00%)
Bid:
827.50
Ask:
830.00
Spread: 2.50 (0.302%)
Market Cap: £951.34m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Trading Statement

1 Sep 2021 07:00

RNS Number : 2990K
Kainos Group plc
01 September 2021
 

1 September 2021

 

Kainos Group plc  

 

("Kainos" or "the Company")  

 

Trading Update 

 

Kainos Group plc (KNOS), a leading IT provider, operating across two specialist business areas, Digital Services and its Workday Practice, today issues a trading update for the period from 1 April 2021 to date.  

 

Trading in the period continues to be resilient across both business areas as organisations continue to increase their investment in digital solutions. Our performance is further enhanced by our long-term customer relationships and the expansion of our revenues across customers, markets and geographic regions. 

 

As a result, for the full year ending 31 March 2022, the Board expects revenue to be ahead of current consensus forecasts and adjusted profit to be in line with consensus forecasts. Strong recruitment during the period has increased headcount to 2,409 as at 31 August 2021 (31 March 2021: 2,024).

 

Along with the support of our customers, we recognise that our business performance has been driven by the exceptional commitment of our people who continue to demonstrate phenomenal energy, flexibility and resilience. We are grateful to our customers and colleagues for the ongoing trust that they have placed in Kainos.

 

Growth in Digital Services continues to be strong as demand across the Public, Commercial and Healthcare sectors in the UK remains robust. Internationally, we are encouraged by our early progress as we expand our client base in Europe and North America.

 

Within the Workday Practice, we continue to benefit from the established geographic scope of our business, and we have secured significant new consulting contracts nationally and internationally. Smart Test, our Workday automated testing platform, continues to win new clients and drive very strong growth, and we are delighted to launch Smart Audit.

 

While the ongoing economic disruption caused by Covid-19 will be a feature in future trading periods, our outlook remains confident, which reflects our significant pipeline and robust backlog.

 

The announcement of our results for the six months ended 30 September 2021 will be made on Monday 15 November 2020.

 

Ends 

 

 

For further information, please contact: 

 

Kainosvia FTI Consulting LLP 

Brendan Mooney, Chief Executive Officer 

Richard McCann, Chief Financial Officer 

 

Investec Bank plc+44 20 7597 5970 

Patrick Robb / Ben Griffiths 

 

Canaccord Genuity+44 20 7523 4606 

Simon Bridges / Andrew Potts 

 

FTI Consulting LLP+44 20 3727 1000 

Matt Dixon / Dwight Burden / Kwaku Aning  

 

About Kainos 

Kainos Group plc is a UK-headquartered IT provider, across two specialist business areas, Digital Services and the Workday Practice.

 

The Group's Digital Services include full lifecycle development and support of customised Digital Services for public sector, healthcare and commercial customers. These transformative solutions encompass a range of services from experience design to artificial intelligence and cloud to deliver truly intelligent solutions that are secure, accessible and cost-effective.

 

The Group's Workday Practice is one of WorkdayÕs most respected partners. As a full-service partner, we are experienced in complex deployment and integrations, and the leader in Workday test automation.

WeÕre trusted by our customers to launch, test, expand and safeguard their Workday systems.

 

Kainos has over 2,000 people across 12 offices in Europe and North America. Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com. 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSDEFAFEFSEFA
Date   Source Headline
18th Nov 20247:00 amRNSTransaction in Own Shares
15th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 202412:32 pmRNSDirector / PDMR shareholdings
11th Nov 20247:01 amRNSShare buyback programme
11th Nov 20247:00 amRNSInterim Results
31st Oct 20247:00 amRNSTrading Update
1st Oct 20249:49 amRNSTotal Voting Rights
24th Sep 20241:11 pmRNSBoard Changes
24th Sep 20241:06 pmRNSResults of Annual General Meeting
9th Sep 202410:14 amRNSHolding(s) in Company
2nd Sep 202411:13 amRNSTotal Voting Rights
2nd Sep 20247:00 amRNSTrading Statement
15th Aug 202410:00 amRNSNotice of AGM
1st Aug 202410:34 amRNSTotal Voting Rights
31st Jul 20244:41 pmRNSAnnual Report 2024
25th Jul 20242:30 pmRNSWorkday Partnership & Co-Sell drives £200m Target
11th Jul 202410:26 amRNSTR-1: Notification of major holdings
2nd Jul 20249:57 amRNSDirector / PDMR shareholdings
1st Jul 20249:23 amRNSTotal Voting Rights
3rd Jun 20243:53 pmRNSDirector/PDMR Shareholding
3rd Jun 202410:36 amRNSTotal Voting Rights
20th May 20247:01 amRNSBoard and Board Committee Changes
20th May 20247:00 amRNSFull year results
1st May 202412:00 pmRNSTotal Voting Rights
15th Apr 20247:00 amRNSYear-end Trading Update
11th Apr 20243:50 pmRNSHolding(s) in Company
2nd Apr 202412:12 pmRNSTotal Voting Rights
15th Mar 20241:48 pmRNSHolding(s) in Company
28th Feb 20243:16 pmRNSHolding(s) in Company
5th Feb 202412:51 pmRNSHolding(s) in Company
1st Feb 20244:29 pmRNSHolding(s) in Company
1st Feb 20244:21 pmRNSHolding(s) in Company
1st Feb 202412:13 pmRNSTotal Voting Rights
31st Jan 20244:09 pmRNSDirector/PDMR Shareholding
2nd Jan 202412:15 pmRNSTotal Voting Rights
22nd Dec 20239:21 amRNSExecutive Director PSP Award/PDMR shareholdings
1st Dec 20239:35 amRNSTotal Voting Rights
17th Nov 202311:13 amRNSExecutive Director PSP Award/PDMR shareholdings
13th Nov 20237:00 amRNSInterim Results
1st Nov 202310:48 amRNSTotal Voting Rights
2nd Oct 202312:41 pmRNSTotal Voting Rights
2nd Oct 20237:00 amRNSConfirmation of Board Changes
27th Sep 20235:52 pmRNSDirector/PDMR Shareholding
21st Sep 20232:54 pmRNSResults of Annual General Meeting
21st Sep 202311:59 amRNSConfirmation of CEO appointment
1st Sep 202312:34 pmRNSTotal Voting Rights
31st Aug 20237:00 amRNSTrading Update
10th Aug 20232:48 pmRNSNotice of AGM
3rd Aug 202310:41 amRNSMount Charles & Bankmore Square, Belfast

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.